Robert Hans Ingemar Andtbacka, MD, CM, Huntsman Cancer Institute
Advertisement
Articles by Robert Hans Ingemar Andtbacka, MD, CM, Huntsman Cancer Institute
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Mocertatug Rezetecan Drives Rapid, Deep Responses in Platinum-Resistant Ovarian and Recurrent/Advanced Endometrial Cancer
2
Iza-Bren Improves Survival in Unresectable, Locally Advanced or Metastatic TNBC
3
Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer
4
Zongertinib, Sevabertinib Reshape Treatment Landscape for Patients With HER2-Mutated NSCLC
5